T raditional approaches to studying the in vivo functionality of regulatory elements controlling gene expression involve pronuclear injection of promoter/enhancer sequences linked to a reporter gene (eg, lacZ) . These experiments are limited by the out-of-genomic-context in which the sequences are studied and the necessity of generating multiple lines of mice to address issues surrounding copy number-and position-dependent effects on reporter gene activity as well as untoward consequences of foreign DNA sequences on the genomic landscape that could perturb endogenous gene expression. 1 The emergence of artificial chromosome-mediated transgenic mice represented an important step toward the study of gene expression in proper genomic context, 2 but these large-capacity cloning vectors are difficult to work with and still require the generation of multiple independent lines of mice, which can take months to years to complete. Thus, newer facile methods of analyzing regulatory elements in their native genomic milieu are needed.
See cover image
The CRISPR/Cas9 system, defined originally as a heritable, adaptive immune system in bacteria and archaea, 3 has recently been harnessed as an RNA-guided nuclease method of genome editing in several animal species, including zebrafish, 4 pig, 5 rat, 6 mouse, 7 rabbit, 8 and monkey. 9 In what we shall refer to as 3-component CRISPR (3cCRISPR), a guide RNA (gRNA)-comprising a 20-nucleotide CRISPR RNA plus the invariant transactivating RNA-is combined with Cas9 endonuclease mRNA and a single-strand oligonucleotide overlapping the gRNA-targeted sequence for delivery to fertilized eggs. Precise genome editing occurs after sequential gRNA-Cas9-mediated DNA double-strand break at the genomic region of interest and homology-directed repair of the double-strand break by a single-strand oligonucleotide harboring ≈60 nucleotide homology arms flanking DNA substitutions (for mutating endogenous DNA sequences) or exogenous sequences (eg, restriction site, loxP) that are stably integrated at the site of repair. 10, 11 Although this programmable endonuclease approach to genome editing has been deployed successfully to modify protein-coding genes in vivo, there has yet to be a report on its use in altering regulatory elements controlling gene expression in a living animal. 12 In this context, there is an emerging need to elucidate the functionality of regulatory single nucleotide polymorphisms because most genomic variation associated with human disease occurs in noncoding sequence space where millions of regulatory elements reside. 13 Herein, we demonstrate CRISPR-Cas9mediated mutation of a regulatory element that nearly abolishes the expression of the endogenous Cnn1 gene in mouse tissues.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results
CArG boxes bind serum response factor (SRF) around a growing number of target genes, including most smooth muscle cell (SMC)-restricted genes. 14 We used 3cCRISPR to introduce nucleotide substitutions within a consensus intronic CArG box of the endogenous mouse Cnn1 gene ( Figure 1A ). This particular CArG box is suspected to play an important role in the endogenous expression of Cnn1. 15, 16 Initial pronuclear injections of plasmid DNA carrying Cas9 and the gRNA were unsuccessful in generating mutant mice. However, cytoplasmic injection of Cas9 mRNA, purified gRNA, and a single-strand oligonucleotide homology-directed repair template resulted in 3 of 18 pups with either one (n=2) or both (n=1) alleles correctly edited as indicated by a restriction fragment length polymorphism assay ( Figure 1B ) and a novel multiplex polymerase chain reaction assay we have developed for the unambiguous genotyping of subtle mutations introduced into the genome ( Figure 1C ; Figure I in the online-only Data Supplement). Offtarget mutations of related sequences in the genome were limited and, when present (2/10) in founder mice, affected only nonconserved intergenic sequences ( Table I in the online-only Data Supplement). Importantly, repeat sequencing of these sites in F 1 mice revealed the absence of mutations, indicating that the off-target edits were successfully bred out of the genome. Quantitative reverse transcription polymerase chain reaction analysis of the biallelic targeted founder mouse showed significant decreases in Cnn1 mRNA expression in aorta and bladder ( Figure II 
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reduced Cnn1 mRNA expression was not the result of spurious mutations outside of the targeted CArG box. In agreement with mRNA expression analysis, Western blotting revealed low levels of CNN1 protein in the aorta of Cnn1 ΔCArG/ΔCArG mice ( Figure 2B ; Figure III in the online-only Data Supplement). As expected from previous CArG mutagenesis experiments, 15 in vivo chromatin immunoprecipitation assay showed essentially no binding of SRF to the mutant intronic CArG box ( Figure 2C ). Confocal immunofluorescence microscopy confirmed a clear reduction in the expression of CNN1 protein in SMC of the carotid artery ( Figure 2D ) and other SMCcontaining tissues (data not shown). There was no change in mRNA or protein expression of several SMC-restricted markers under similar CArG-SRF regulatory control ( Figure III in the online-only Data Supplement). CNN1 has been reported to function as a tumor suppressor gene. 17 Consistent with this idea, we noted a significant increase in the number of Ki-67-positive cells per longitudinal section of carotid artery in Cnn1 ΔCArG/ΔCArG mice (21.7±2.1) when compared with Cnn1 +/+ mice (7.7±4.0) (mean Ki67 + cells ± std, n=3, P=0.0334; Figure 2E ). Because Cnn1 ΔCArG/ΔCArG mice are viable, they represent a valuable resource to further characterize the phenotypic changes associated with marked reductions in CNN1 under normal and pathological conditions.
Discussion
In this report, we used 3cCRISPR to mutate a regulatory element controlling gene expression in a living animal. We found that a three nucleotide substitution within an intronic SRF-binding CArG box, suggested previously to be of potential importance in the expression of the endogenous Cnn1 gene, 15, 16 nearly abrogates expression of Cnn1 mRNA and CNN1 protein in SMC of the vessel wall, without altering expression of a number of other CArG-SRFdependent genes. Detectable CNN1 protein in the vessel wall of mutant mice suggests that there may be additional cis elements (such as downstream CArG boxes) directing low-level expression of the gene. We also note an increase in the number of SMC undergoing DNA synthesis in the vessel wall of mice carrying the CArG box mutation. The fact that no other local mutations were present, and congruent results were found in independent founder mice, indicate that the phenotypes observed are a consequence of a loss in SRF binding to the mutant intronic CArG box. To our knowledge, this study provides the first genetic proof for a decisive role of a single regulatory element inducing a target gene's expression in vivo without the introduction of foreign DNA sequences or deletion of native sequences. Genetically inactivating genes, whether protein-coding or otherwise, is common practice in the laboratory. For example, a CArG box in the proximal promoter of the Telokin gene was deleted with some flanking sequences using Cre-mediated excision, and this deletion resulted in the loss of Telokin expression with consequent changes in the tone of intestinal smooth muscle. 18 Such experimentation is crucial to study the functional consequences associated with the loss of gene products and to gain insight into the potential role of regulatory elements, such as CArG boxes, in the setting of a living animal. Traditional methods of deleting a gene in this manner require complex design and validation of a targeting vector followed by the time-consuming steps of electroporating the targeting vector into embryonic stem cells, enrichment and screening of embryonic stem cells for correct targeting, transference of the embryonic stem cell clone into the blastocyst, and breeding of chimeric mice for germline transmission of the targeted allele. 19, 20 Because of the protracted time in generating genetically altered mice with this traditional approach, coupled with the complexity and redundancy of gene regulation, there have been far fewer regulatory knockouts when compared with genic knockouts. Furthermore, genic control regions, such as enhancers, have almost always been deleted via Cre recombinase-mediated excision of 100s to 1000s of nucleotides, effectively leaving a genomic cavity. [21] [22] [23] Although these studies certainly provide some insight into the role of enhancers in target gene expression and animal pathophysiology, they lack resolution in narrowing down specific elements within the enhancer that mediate gene expression. Moreover, foreign DNA sequences, such as loxP sites or the neomycin selectable marker, can alter the expression of local and/or distal genes, thus confounding accurate interpretation of knockout phenotypes. 24 In contrast, the application of 3cCRISPR, as implemented here, provides exquisite genomic editing such that subtle nucleotide substitutions are introduced without deleting sequences or introducing any foreign DNA sequences. This revolutionary technology, therefore, offers an unprecedented experimental approach to precisely model regulatory variants, including previously identified human CArG-SNPs, 25 that may contribute to human disease. We predict 3cCRISPR will find widespread use in the analysis of regulatory elements and will likely supplant traditional approaches to their functional study in transgenic animals.
